CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 29 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 17 | -98.2% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 936 | -52.2% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 1,960 | -93.6% | 0.00% | – |
| Q3 2022 | $44,000 | +29.4% | 30,460 | -3.5% | 0.00% | – |
| Q2 2022 | $34,000 | +325.0% | 31,549 | +1000.4% | 0.00% | – |
| Q1 2022 | $8,000 | -75.0% | 2,867 | -65.7% | 0.00% | – |
| Q4 2021 | $32,000 | – | 8,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |